The story previously incorrectly reported that CDI received a $16 million grant to create 3 iPSC lines. The grant was for the company to create 3 iPSC lines for each of 3,000 selected donors.

NEW YORK (GenomeWeb News) – Two investment banks today initiated coverage of stem cell firm Cellular Dynamics International, noting sizeable and growing market opportunities for the Madison, Wis.-based firm's technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.